Y chromosome and HIV DNA detection in vaginal swabs as biomarkers of semen and HIV exposure in women

Sexually Transmitted Diseases

Volumn 41, Issue 11, 2014, Pages 674-679

  Penrose, Kerri J ^a   Richardson, Barbra A ^b   Besson, Guillaume ^a   Dezzutti, Charlene S ^a,c   Herold, Betsy C ^d   Abdool Karim, Salim S ^e   Mellors, John W ^a   Parikh, Urvi M ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICROBICIDE; VIRUS DNA; PRIMER DNA;

ARTICLE; CLINICAL ARTICLE; COITUS; CONDOM USE; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LIMIT OF DETECTION; POLYMERASE CHAIN REACTION; SELF REPORT; SEROCONVERSION; SEXUAL BEHAVIOR; SPERM; UNPROTECTED SEX; VAGINA; Y CHROMOSOME; ADULT; CASE CONTROL STUDY; CHEMISTRY; CLINICAL TRIAL; CONDOM; GENETICS; ISOLATION AND PURIFICATION; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; UTILIZATION; VAGINA SMEAR; VIROLOGY;

ADULT; BIOMARKERS; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, Y; COITUS; CONDOMS; DNA PRIMERS; DNA, VIRAL; FEMALE; HIV-1; HUMANS; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; SELF REPORT; SEMEN; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; VAGINA; VAGINAL SMEARS;

EID: 84930036415     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0000000000000191     Document Type: Article

References (29)

1. Mauck CK, Doncel GF. Biomarkers of semen in the vagina: applications in clinical trials of contraception and prevention of sexually transmitted pathogens including HIV. Contraception 2007; 75:407-419.
2. Mauck CK. Biomarkers for evaluating vaginal microbicides and contraceptives: Discovery and early validation. Sex Transm Dis 2009; 36(3 suppl):S73-S75.
3. Anglewicz P, Gourvenec D, Halldorsdottir I, et al. The effect of interview method on self-reported sexual behavior and perceptions of community norms in Botswana. AIDS Behav 2013; 17:674-687.
4. Pool R, Montgomery CM, Morar NS, et al. Assessing the accuracy of adherence and sexual behaviour data in the MDP301 vaginal microbicides trial using a mixed methods and triangulation model. PLoS One 2010; 5:e11632.
5. Marrazzo J, Ramjee G, Nair G, et al. Pre-exposure prophylaxis for HIV in women: Daily oral tenofovir, oral tenofovir/emtricitabine or vaginal tenofovir gel in the VOICE study (MTN 003). 20th Conference on Retroviruses and Opportunistic Infections, Atlanta, GA; 2013.
6. Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med 2012; 367:423-434.
7. Van Damme L, Corneli A, Ahmed K, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med 2012; 367: 411-422.
8. Minnis AM, Steiner MJ, Gallo MF, et al. Biomarker validation of reports of recent sexual activity: Results of a randomized controlled study in Zimbabwe. Am J Epidemiol 2009; 170:918-924.
9. Bahamondes L, Diaz J, Marchi NM, et al. Prostate-specific antigen in vaginal fluid after exposure to known amounts of semen and after condom use: Comparison of self-collected and nurse-collected samples. Hum Reprod 2008; 23:2444-2451.
10. Jamshidi R, Penman-Aguilar A, Wiener J, et al. Detection of two biological markers of intercourse: Prostate-specific antigen and Y-chromosomal DNA. Contraception 2013; 88:749-757.
11. Macaluso M, Lawson L, Akers R, et al. Prostate-specific antigen in vaginal fluid as a biologic marker of condom failure. Contraception 1999;59:195-201.
12. Abbott SA, Friedland BA, Sarna A, et al. An evaluation of methods to improve the reporting of adherence in a placebo gel trial in Andhra Pradesh, India. AIDS Behav 2013; 17:2222-2236.
13. Simson Oechsle C, Haddad S, Sgueglia JB, et al. Screening biological stains with qPCR versus lateral flow immunochromatographic test strips: A quantitative comparison using analytical figures of merit. J Forensic Sci 2014; 59:199-207.
14. Brotman RM, Melendez JH, Smith TD, et al. Effect of menses on clearance of Y-chromosome in vaginal fluid: Implications for a bio-marker of recent sexual activity. Sex Transm Dis 2010; 37:1-4.
15. Zenilman JM, Yuenger J, Galai N, et al. Polymerase chain reaction detection of Y chromosome sequences in vaginal fluid: Preliminary studies of a potential biomarker for sexual behavior. Sex Transm Dis 2005; 32:90-94.
16. Melendez JH, Giles JA, Yuenger JD, et al. Detection and quantification of Y-chromosomal sequences by real-time PCR using the LightCycler system. Sex Transm Dis 2007; 34:617-619.
17. Ghanem KG, Melendez JH, McNeil-Solis C, et al. Condom use and vaginal Y-chromosome detection: The specificity of a potential bio-marker. Sex Transm Dis 2007; 34:620-623.
18. Basu J, Romney SL, Angeletti RH, et al. Human immunodeficiency virus (HIV) antigens and RNA in HIV-seronegative women with cervical intraepithelial neoplasia. AIDS Res Hum Retroviruses 2009; 25:249-259.
19. Mermin JH, Holodniy M, Katzenstein DA, et al. Detection of human immunodeficiency virus DNA and RNA in semen by the polymerase chain reaction. J Infect Dis 1991; 164:769-772.
20. Ball JK, Curran R, Irving WL, et al. HIV-1 in semen: Determination of proviral and viral titres compared to blood, and quantification of semen leukocyte populations. J Med Virol 1999; 59:356-363.
21. Zhang H, Dornadula G, Beumont M, et al. Human immunodeficiency virus type 1 in the semen of men receiving highly active anti-retroviral therapy. N Engl J Med 1998; 339:1803-1809.
22. Lambert-Niclot S, Tubiana R, Beaudoux C, et al. Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma on a 2002-2011 survey. AIDS 2012; 26:971-975.
23. Abdool Karim SS, Richardson BA, Ramjee G, et al. Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women. AIDS 2011;25:957-966.
24. Dezzutti CS, Richardson BA, Marrazzo JM, et al. Mucosal Escherichia coli bactericidal activity and immune mediators are associated with HIV-1 seroconversion in women participating in the HPTN 035 trial. J Infect Dis 2012; 206:1931-1935.
25. Cillo AR, Krishnan A, Mitsuyasu RT, et al. Plasma viremia and cellular HIV-1 DNA persist despite autologous hematopoietic stem cell transplantation for HIV-related lymphoma. J Acquir Immune Defic Syndr 2013; 63:438-441.
26. + T cells in semen during HIV infection and their restoration following antire-troviral therapy. J Acquir Immune Defic Syndr 2009; 50:283-289.
27. Walsh TL, Frezieres RG, Peacock K, et al. Use of prostate-specific antigen (PSA) to measure semen exposure resulting from male condom failures: Implications for contraceptive efficacy and the prevention of sexually transmitted disease. Contraception 2003; 67:139-150.
28. Jadack RA, Yuenger J, Ghanem KG, et al. Polymerase chain reaction detection of Y-chromosome sequences in vaginal fluid of women accessing a sexually transmitted disease clinic. Sex Transm Dis 2006; 33:22-25.
29. Phillips AE, Gomez GB, Boily MC, et al. A systematic review and meta-analysis of quantitative interviewing tools to investigate self-reported HIV and STI associated behaviours in low-and middle-income countries. Int J Epidemiol. 2010;39(6):1541-1555.